NYSE:GEN

Stock Analysis Report

Executive Summary

Genesis Healthcare, Inc., together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the United States.

Snowflake

Fundamentals

Slightly overvalued with weak fundamentals.

Risks

  • Genesis Healthcare has significant price volatility in the past 3 months.

Similar Companies

Share Price & News

How has Genesis Healthcare's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-1.3%

NYSE:GEN

-3.5%

US Healthcare

-1.9%

US Market


1 Year Return

-41.3%

NYSE:GEN

-9.0%

US Healthcare

-3.3%

US Market

GEN underperformed the Healthcare industry which returned -8.9% over the past year.

GEN underperformed the Market in United States of America which returned -3% over the past year.


Share holder returns

GENIndustryMarket
7 Day-1.3%-3.5%-1.9%
30 Day-14.8%-4.6%-6.2%
90 Day-16.9%-0.2%0.3%
1 Year-41.3%-41.3%-7.6%-9.0%-1.1%-3.3%
3 Year-58.8%-58.8%27.2%22.0%37.9%28.9%
5 Yearn/a62.4%52.9%50.8%34.1%

Price Volatility Vs. Market

How volatile is Genesis Healthcare's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Genesis Healthcare undervalued based on future cash flows and its price relative to the stock market?

>50%

Discount to future cash flow value


Intrinsic Value Based on Future Cash Flows

Genesis Healthcare's share price is below the future cash flow value, and at a moderate discount (> 20%).

Genesis Healthcare's share price is below the future cash flow value, and at a substantial discount (> 40%).


Price Based on Earnings

Genesis Healthcare is loss making, we can't compare its value to the US Healthcare industry average.

Genesis Healthcare is loss making, we can't compare the value of its earnings to the United States of America market.


Price Based on Expected Growth

Unable to calculate PEG ratio for Genesis Healthcare, we can't assess if its growth is good value.


Price Based on Value of Assets

Genesis Healthcare has negative assets, we can't compare the value of its assets to the US Healthcare industry average.


Next Steps

Future Growth

How is Genesis Healthcare expected to perform in the next 1 to 3 years based on estimates from 4 analysts?

37.2%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

Genesis Healthcare's revenue is expected to decrease over the next 1-3 years, this is not considered high growth.

Genesis Healthcare is not considered high growth as it is expected to be loss making for the next 1-3 years.

Genesis Healthcare's revenues are expected to decrease over the next 1-3 years, this is below the United States of America market average.

Unable to compare Genesis Healthcare's earnings growth to the United States of America market average as it is expected to be loss making during the next 1-3 years.

Unable to compare Genesis Healthcare's earnings growth to the low risk savings rate as it is expected to be loss making during the next 1-3 years.


Earnings per Share Growth Estimates


Future Return on Equity

Unable to establish if Genesis Healthcare will efficiently use shareholders’ funds in the future without estimates of Return on Equity.


Next Steps

Past Performance

How has Genesis Healthcare performed over the past 5 years?

-3.0%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Genesis Healthcare does not make a profit and their year on year earnings growth rate was negative over the past 5 years.

Unable to compare Genesis Healthcare's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare Genesis Healthcare's 1-year growth to the US Healthcare industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if Genesis Healthcare has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) due to its liabilities exceeding its assets.


Return on Assets

Genesis Healthcare used its assets less efficiently than the US Healthcare industry average last year based on Return on Assets.


Return on Capital Employed

It is difficult to establish if Genesis Healthcare improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.


Next Steps

Financial Health

How is Genesis Healthcare's financial position?


Financial Position Analysis

Genesis Healthcare's short term (1 year) commitments are greater than its holdings of cash and other short term assets.

Genesis Healthcare's long term commitments exceed its cash and other short term assets.


Debt to Equity History and Analysis

Genesis Healthcare has negative shareholder equity (liabilities exceed assets), this is a more serious situation compared with a high debt level.

Irrelevant to check if Genesis Healthcare's debt level has increased considering it has negative shareholder equity.


Balance Sheet

High level of physical assets or inventory.

Genesis Healthcare has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Genesis Healthcare has less than a year of cash runway based on current free cash flow.

Genesis Healthcare has less than a year of cash runway if free cash flow continues to grow at historical rates of 91.3% each year.


Next Steps

Dividend

What is Genesis Healthcare's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Genesis Healthcare's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Genesis Healthcare's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Genesis Healthcare has not reported any payouts.

Unable to verify if Genesis Healthcare's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Genesis Healthcare has not reported any payouts.


Future Payout to Shareholders

No need to calculate the sustainability of Genesis Healthcare's dividends in 3 years as they are not expected to pay a notable one for United States of America.


Next Steps

Management

What is the CEO of Genesis Healthcare's salary, the management and board of directors tenure and is there insider trading?

4.5yrs

Average management tenure


CEO

George Hager (63yo)

4.5yrs

Tenure

US$2,227,878

Compensation

Mr. George V. Hager, Jr. has been the Chief Executive Officer of Genesis Healthcare, Inc. since February 2, 2015. From 2003 until 2015, Mr. Hager served as Chief Executive Officer of Genesis LLC. Prior to  ...


CEO Compensation Analysis

George's remuneration is higher than average for companies of similar size in United States of America.

George's compensation has increased whilst company is loss making.


Management Age and Tenure

4.5yrs

Average Tenure

60yo

Average Age

The tenure for the Genesis Healthcare management team is about average.


Board Age and Tenure

4.5yrs

Average Tenure

65yo

Average Age

The tenure for the Genesis Healthcare board of directors is about average.


Insider Trading

Genesis Healthcare individual insiders have only sold shares in the past 3 months.


Recent Insider Transactions

SellUS$8,66314 Jun 19
Stephen Young
EntityIndividual
Shares7,416
Max PriceUS$1.17
SellUS$9,01414 Jun 19
Michael Sherman
EntityIndividual
Role
Chief Legal Officer
Senior VP
Shares7,716
Max PriceUS$1.17
SellUS$12,54414 Jun 19
JoAnne Reifsnyder
EntityIndividual
Role
Senior Key Executive
Executive VP of Clinical Operations & Chief Nursing Officer
Shares10,738
Max PriceUS$1.17
SellUS$14,92314 Jun 19
Thomas DiVittorio
EntityIndividual
Role
Chief Financial Officer
CFO, Executive VP
Shares12,774
Max PriceUS$1.17
SellUS$14,50714 Jun 19
Paul Bach
EntityIndividual
Role
Chief Operating Officer
COO & Executive VP
Shares12,418
Max PriceUS$1.17
SellUS$4,29605 Jun 19
Stephen Young
EntityIndividual
Shares3,706
Max PriceUS$1.16
SellUS$5,53805 Jun 19
Michael Sherman
EntityIndividual
Role
Chief Legal Officer
Senior VP
Shares4,777
Max PriceUS$1.16
SellUS$7,11305 Jun 19
JoAnne Reifsnyder
EntityIndividual
Role
Senior Key Executive
Executive VP of Clinical Operations & Chief Nursing Officer
Shares6,136
Max PriceUS$1.16
SellUS$8,93405 Jun 19
Thomas DiVittorio
EntityIndividual
Role
Chief Financial Officer
CFO, Executive VP
Shares7,706
Max PriceUS$1.16
SellUS$9,98905 Jun 19
Paul Bach
EntityIndividual
Role
Chief Operating Officer
COO & Executive VP
Shares8,616
Max PriceUS$1.16
SellUS$6,73022 May 19
Stephen Young
EntityIndividual
Shares5,609
Max PriceUS$1.20
SellUS$7,67722 May 19
Michael Sherman
EntityIndividual
Role
Chief Legal Officer
Senior VP
Shares6,398
Max PriceUS$1.20
SellUS$9,58722 May 19
JoAnne Reifsnyder
EntityIndividual
Role
Senior Key Executive
Executive VP of Clinical Operations & Chief Nursing Officer
Shares7,990
Max PriceUS$1.20
SellUS$12,38122 May 19
Thomas DiVittorio
EntityIndividual
Role
Chief Financial Officer
CFO, Executive VP
Shares10,318
Max PriceUS$1.20
SellUS$13,84722 May 19
Paul Bach
EntityIndividual
Role
Chief Operating Officer
COO & Executive VP
Shares11,540
Max PriceUS$1.20
SellUS$2,660,00029 Nov 18
David Reis
EntityIndividual
Shares2,000,000
Max PriceUS$1.33
SellUS$89,14909 Nov 18
David Reis
EntityIndividual
Shares53,369
Max PriceUS$1.68

Ownership Breakdown


Management Team

  • George Hager (63yo)

    CEO & Director

    • Tenure: 4.5yrs
    • Compensation: US$2.23m
  • Jim Tabak (60yo)

    Senior Vice President of Administration & Government Affairs

    • Tenure: 0.0yrs
  • Rich Castor (64yo)

    Chief Information Officer & Senior VP

    • Tenure: 0.0yrs
  • Dick Blinn (65yo)

    Executive VP and President of Northeast & Southeast Divisions

    • Tenure: 15.7yrs
    • Compensation: US$372.17k
  • Tom DiVittorio (51yo)

    CFO, Executive VP

    • Tenure: 4.5yrs
    • Compensation: US$1.06m
  • Paul Bach (60yo)

    COO & Executive VP

    • Tenure: 2.6yrs
    • Compensation: US$1.06m
  • JoAnne Reifsnyder (60yo)

    Executive VP of Clinical Operations & Chief Nursing Officer

    • Tenure: 4.5yrs
    • Compensation: US$815.06k
  • Mike Sherman (50yo)

    Senior VP

    • Tenure: 4.5yrs
    • Compensation: US$729.74k
  • John Raley

    Senior Vice President of Human Resources

    • Tenure: 1.6yrs
  • Lori Mayer

    Vice President of Investor Relations

    • Tenure: 0.0yrs

Board Members

  • George Hager (63yo)

    CEO & Director

    • Tenure: 4.5yrs
    • Compensation: US$2.23m
  • Jim McKeon (54yo)

    Director

    • Tenure: 4.5yrs
    • Compensation: US$273.05k
  • Terry Rappuhn (62yo)

    Director

    • Tenure: 2.6yrs
    • Compensation: US$268.05k
  • John DePodesta (74yo)

    Independent Director

    • Tenure: 4.5yrs
    • Compensation: US$278.39k
  • Jim Bloem (69yo)

    Independent Director

    • Tenure: 4.5yrs
    • Compensation: US$271.39k
  • Bob Fish (68yo)

    Chairman & Lead Independent Director

    • Tenure: 2.3yrs
    • Compensation: US$350.89k
  • Arnie Whitman (67yo)

    Director

    • Tenure: 4.5yrs
    • Compensation: US$246.39k
  • Robert Hartman (62yo)

    Director

    • Tenure: 4.5yrs
    • Compensation: US$253.05k

Company Information

Genesis Healthcare, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Genesis Healthcare, Inc.
  • Ticker: GEN
  • Exchange: NYSE
  • Founded: 2003
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Implied Market Cap: US$164.317m
  • Market Cap: US$107.855m
  • Shares outstanding: 164.78m
  • Website: https://www.genesishcc.com

Number of Employees


Location

  • Genesis Healthcare, Inc.
  • 101 East State Street
  • Kennett Square
  • Pennsylvania
  • 19348
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
GENNYSE (New York Stock Exchange)YesClass A Common StockUSUSDFeb 2015
SH11DB (Deutsche Boerse AG)YesClass A Common StockDEEURFeb 2015

Biography

Genesis Healthcare, Inc., together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the United States. The company operates through three segment ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/08/26 00:10
End of Day Share Price2019/08/23 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.